Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 124.60
Bid: 124.60
Ask: 125.00
Change: 1.20 (0.97%)
Spread: 0.40 (0.321%)
Open: 123.20
High: 125.60
Low: 123.20
Prev. Close: 123.40
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intention to undertake equity fundraising

31 Jan 2013 10:30

RNS Number : 7911W
HICL Infrastructure Company Ld
31 January 2013
 



HICL Infrastructure Company Limited (the "Company")

 

31 January 2013

 

Intention to undertake equity fundraising

 

The Board of HICL Infrastructure Company Limited is pleased to announce that it intends to proceed with a Placing, Open Offer and Offer for Subscription of Ordinary Shares (the "Issue") during the first quarter of this year.

 

In the Company's announcement of 17 December 2012, it was noted that the Company's ability to issue shares by way of 'tap' has been fully utilised for the time being, and that any further issue of shares on a non-pre-emptive basis would only be permitted following the requisite grant of authority by shareholders at a general meeting of the Company. The pipeline of potential new business remains healthy, and the Company's Investment Adviser is confident that further attractive investment opportunities will arise in the coming months. In light of the Group's current funding requirement of approximately £30m, and in anticipation of further investments being made, it is now the Board's intention to publish a prospectus in relation to the Issue, and to convene a general meeting for the purposes of seeking shareholder approval for the Issue.

 

As with previous formal equity fundraisings by the Company, the inclusion of an Open Offer will ensure that a portion of the Issue is reserved in the first instance exclusively for existing shareholders. Further details as to the precise timing and quantum of the Issue will be announced in due course. For indicative purposes, however, it is envisaged that a prospectus will be published in February, and that (subject to shareholder approval) the new Ordinary Shares will be issued and commence trading by the end of March. In terms of the size of the Issue, the Board will continue to observe the policy that the Company should not be cash positive to any material extent, and accordingly the Issue will be limited in size to the aggregate of (i) the Group's funding requirements at the time of publication of the prospectus and (ii) the consideration payable for further investments made or expected to be made by the Group (whether on a conditional or unconditional basis).

 

The Company has typically declared a second interim dividend in April or May of each year. In order to uphold the integrity of the cash cover on the Company's dividend, it is proposed that the record date in respect of the second interim dividend for the financial year ended 31 March 2013 should be brought forward ahead of the date of publication of the prospectus. Accordingly, subscribers for the new Ordinary Shares will not be entitled to this second interim dividend.

 

A further announcement giving full details of the Issue will be made at the time of publication of the prospectus.

 

 

Enquiries:

InfraRed Capital Partners Limited
020 7484 1800
Tony Roper
 
Keith Pickard
 
Erwan Fournis
 
Robin Hubbard
 
David Foot
 
 
 
Canaccord Genuity Limited
 
Sales Enquiries
 
Dominic Waters
020 7523 8473
Neil Brierley
020 7523 8478
Will Barnett
020 7523 8094
Robbie Robertson
020 7523 8474
Gavin Tooke
020 7523 8470
 
 
Corporate Enquiries
 
David Yovichic
020 7523 8361
Lucy Lewis
020 7523 8360
 
 
Tulchan Communications
020 7353 4200
Ed Orlebar
 
Rebecca Scott
 
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUAOKRONAAORR
Date   Source Headline
26th Sep 20172:30 pmRNSAdditional Listing
14th Sep 20175:31 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSCompletion of Acquisition
1st Sep 20172:11 pmRNSScrip Share Reference Price
26th Jul 20178:25 amRNSPreferred Bidder Announcement
24th Jul 20177:00 amRNSInterim Update Statement
21st Jul 20173:00 pmRNSScrip Dividend Circular
18th Jul 20173:33 pmRNSFirst Quarterly Interim Dividend
14th Jul 20172:50 pmRNSAcquisition
5th Jul 20173:40 pmRNSDirector/PDMR Shareholding
3rd Jul 20175:38 pmRNSTotal Voting Rights
22nd Jun 20172:00 pmRNSAdditional Listing
13th Jun 20178:44 amRNSAnnual General Meeting Circular
13th Jun 20177:00 amRNSAnnual General Meeting Circular
13th Jun 20177:00 amRNSAnnual Financial Report
5th Jun 20173:22 pmRNSResult of Equity Issue
2nd Jun 20171:24 pmRNSScrip Share Reference Price
24th May 20177:00 amRNSAnnual Results for the year ended 31 March 2017
24th May 20177:00 amRNSIssue of Equity
22nd May 20177:00 amRNSCompletion of Acquisition
18th May 201711:21 amRNSFourth Quarterly Interim Dividend
2nd May 20177:00 amRNSAcquisition of a new investment
2nd May 20177:00 amRNSIncrease in the Group's credit facility
10th Apr 20177:00 amRNSNotice of Annual Results
5th Apr 20174:00 pmRNSDirector/PDMR Shareholding
4th Apr 201710:28 amRNSHolding(s) in Company
3rd Apr 20178:00 amRNSIncremental Investment
31st Mar 20175:11 pmRNSTotal Voting Rights
29th Mar 20174:00 pmRNSDirector/PDMR Shareholding
24th Mar 20178:00 amRNSAdditional Listing and Total Voting Rights
22nd Mar 20174:00 pmRNSDirector/PDMR Shareholding
22nd Mar 201710:16 amRNSAdditional Listing
22nd Mar 20177:00 amRNSResult of Equity Issue
21st Mar 20179:28 amRNSTerms and Conditions of the Placing
20th Mar 201711:49 amRNSDirectorate Change
20th Mar 201711:36 amRNSResults of EGM
10th Mar 20178:00 amRNSCompletion of Acquisition
9th Mar 20172:37 pmRNSScrip Share Reference Price
23rd Feb 20175:41 pmRNSPublication of a Prospectus and Circular
23rd Feb 20175:00 pmRNSPublication of a Prospectus and Circular
22nd Feb 20174:45 pmRNSThird Quarterly Interim Dividend
2nd Feb 201711:44 amRNSInterim Update Statement February 2017
23rd Jan 20177:00 amRNSCompletion of Acquisition
12th Jan 20172:42 pmRNSIntention to issue new equity
5th Jan 20177:00 amRNSCompletion of Two Acquisitions
4th Jan 20174:00 pmRNSDirector/PDMR Shareholding
30th Dec 20164:00 pmRNSTotal Voting Rights
16th Dec 201612:32 pmRNSAdditional Listing
7th Dec 20163:45 pmRNSDirector/PDMR Shareholding
2nd Dec 201610:00 amRNSDirector Declaration - Additional Directorship

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.